CNMD Stock Summary and Trading Ideas (Conmed | NYSE:CNMD)

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Conmed trades on the NYSE stock market under the symbol CNMD.

As of February 6, 2025, CNMD stock price declined to $67.36 with 1,152,593 million shares trading.

CNMD has a beta of 0.06, meaning it tends to be less sensitive to market movements. CNMD has a correlation of 0.00 to the broad based SPY ETF.

CNMD has a market cap of $2.08 billion. This is considered a Mid Cap stock.

Last quarter Conmed reported $346 million in Revenue and $1.34 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.14.

In the last 3 years, CNMD traded as high as $155.51 and as low as $61.05.

The top ETF exchange traded funds that CNMD belongs to (by Net Assets): IJR, VTI, IWM, VB, VXF.

CNMD has underperformed the market in the last year with a price return of -17.4% while the SPY ETF gained +24.5%. CNMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.7% and -5.1%, respectively, while the SPY returned +5.5% and 0.0%, respectively.

CNMD support price is $72.02 and resistance is $75.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNMD shares will trade within this expected range on the day.